Publicaciones en las que colabora con María Mar Abad Hernández (31)

2023

  1. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications

    Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257

2019

  1. MEK5 promotes lung adenocarcinoma

    The European respiratory journal

2018

  1. Spatio-temporal tumor heterogeneity in metastatic CRC tumors: A mutational-based approach

    Oncotarget, Vol. 9, Núm. 76, pp. 34279-34288

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

2014

  1. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

    Oncogene, Vol. 33, Núm. 2, pp. 148-156

  2. Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcome

    Journal of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 648-659

  3. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26

  4. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer

    Cancer, Vol. 120, Núm. 13, pp. 1948-1959

2013

  1. C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes

    Epigenetics, Vol. 8, Núm. 6

2012

  1. Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer

    PLoS ONE, Vol. 7, Núm. 11

  2. New models towards assessing anti-cancer therapeutics

    Histology and Histopathology, Vol. 27, Núm. 2, pp. 157-170

  3. Prognostic impact of del(17p) and del(22q) as assessed by interphase FISH in sporadic colorectal carcinomas

    PLoS ONE, Vol. 7, Núm. 8

  4. Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays

    Modern Pathology, Vol. 25, Núm. 4, pp. 590-601

2010

  1. Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis

    Journal of Pathology, Vol. 221, Núm. 3, pp. 308-319

  2. Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. 1, pp. 149-157

2009

  1. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as potential therapeutic target

    PLoS ONE, Vol. 4, Núm. 5

2007

  1. Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663

2006

  1. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 11, Núm. 2, pp. 1

  2. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 11, Núm. 2, pp. 69-74